Abstract:Objective A meta-analysis of randomised controlled trials on the efficacy and safety in patients with Gram-positive cocci infections treated with linezolid versus with vancomycin.Methods The data were collected from the MEDLINE,EMBASE,OVID,the Cochrane library,and CNKI.We also handsearched relevant journals.Randomized controlled trials comparing linezolid with vancomycin in patients with Gram-positive cocci infections were eligible for inclusion.Two investigators independently assessed the quality and extracted the data.The methodological quality of trails was assessed by the Jadad-scale plus allocation concealment.Heterogeneity was examined by chi-square test.Fixed effects model or random effects model were used to pool the data.Sensitivity analyses were used in the treatment course.Results Twelve randomized controlled studies comparing linezolid with vancomycin were analyzed,focusing on the 5,863 patients with Gram-positive cocci infections.It was found by meta-analysis that,with respect to clinical treatment success,linezolid was more effective than vancomycin in clinically evaluation patients at the end-of-treatment visit [OR 1.98,95%CI(1.32,2.98),P=0.001] and at the test-of-cure visit [OR 1.34,95%CI(1.01,1.76),P=0.04],and there was more effective than vancomycin in intention-to-treat patients at the test-of-cure visit [OR 1.20,95%CI(1.01,1.43),P=0.04].With respect to microbiological treatment success,linezolid was more effective than vancomycin in microbiologically evaluation patients at the test-of-cure visit [OR 1.39,95%CI(1.12,1.73),P=0.003].Additionally,empirical treatment with linezolid was associated with increased eradication rates for S.aureus strains [OR=1.84,95%CI(1.39,2.42),P<0.0001] and enterococcal species [OR=5.42,95%CI(1.49,19.71),P=0.01] in comparison with vancomycin in microbiologically evaluation patients at the test-of-cure visit.But,there was no difference in eradication rates for MRSA strains [OR=1.54,95%CI(0.97,2.45),P=0.07],Streptococcal species [OR=0.89,95%CI(0.31,2.54),P=0.82].Mortality was similar between the groups [OR=1.07,95%CI(0.89,1.28),P=0.50].Treatment with linezolid was not associated with more adverse effects in general in comparison with vancomycin [OR=1.10,95%CI(0.83,1.44),P=0.52].Conclusion Linezolid is more effective than vancomycin for treatment of patients with Gram-positive cocci infections although rigorously designed large sample size randomized double blind clinical trials are required to further demonstrate and support the conclusion.

Real-world Study on the Efficacy,Safety and Economics of Vancomycin Hydrochloride for Injection from Two Manufacturers

Multicenter Randomized Controlled Clinical Trial on Teicoplanin Versus Vancomycin

Clinical Response and Hospital Costs Associated with the Empirical Use of Vancomycin and Linezolid for Hospital-Acquired Pneumonia in A Chinese Tertiary Care Hospital: A Retrospective Cohort Study

Comparative Prevalence of Acute Kidney Injury in Chinese Patients Receiving Vancomycin with Concurrent -Lactam Antibiotics: A Retrospective Cohort Study

Model-based Evaluation of the Clinical and Microbiological Efficacy of Vancomycin: A Prospective Study of Chinese Adult In-house Patients

A Prospective Multicenter Clinical Observational Study on Vancomycin Efficiency and Safety with Therapeutic Drug Monitoring.

Glucocorticoids are gastroprotective under physiologic conditions

PP118 the Value of New Antibiotic Treatment Strategies in Zhejiang Province, China

Systematic review and Meta-analysis of continuous versus intermittent infusion of vancomycin

Pharmacoeconomics on Treatment of Gram-Negative Bacteria Infections with Cefoperazone-Sulbactam, Imipenem-Cilastatin, and Piperacillin-Tazobactam

Efficiency of Polymyxin B Treatment Against Nosocomial Infection: a Systematic Review and Meta-Analysis

Linezolid vs vancomycin for the treatment of Gram-positive cocci infections in intensive care uhit patients:meta-analysis for randomized controlled trials

Comparison of omadacycline and meropenem plus linezolid in treatment of pulmonary infection: A real-world cohort study

The Benefit of Individualized Vancomycin Dosing Via Pharmacokinetic Tools: A Systematic Review and Meta-analysis

Clinical efficacy of intrathecal injection of vancomycin in treatment of postoperative intracranial infections in neurosurgery department patients

Linezolid versus vancomycin for treatment of Gram-positive cocci infections:Meta-analysis of randomised controlled trials

A randomized, double-blinded, controlled, multicenter clinical trial of linezolid versus vancomycin in the treatment of gram positive bacterial infection

Vancomycin Serum Trough Concentration Vs. Clinical Outcome in Patients with Gram-Positive Infection: a Retrospective Analysis.

EVALUATION OF INTERVENTIONS BY PHARMACISTS IN VANCOMYCIN TREATMENT IN CHINESE ADULT PNEUMONIA PATIENTS: A RANDOMIZED CONTROLLED TRIAL

Analysis on Rationality of Vancomysin Use in Our Hospital

Cost-Effectiveness Analysis of Xiyanping Injection (andrographolide Sulfonate) for Treatment of Adult Community Acquired Pneumonia: A Retrospective, Propensity Score-Matched Cohort Study